問卷

TPIDB > Search Result

Search Result

篩選

List

13Cases

2023-02-01 - 2026-12-31

Phase II

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2022-05-01 - 2023-07-21

Phase II/III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2020-05-01 - 2026-12-31

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2023-01-05 - 2026-12-13

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
5Sites

Recruiting5Sites

2023-02-15 - 2025-06-30

Phase I

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Recruiting10Sites

Terminated1Sites

2023-06-01 - 2026-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2023-11-09 - 2032-11-22

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
7Sites

Recruiting7Sites

2024-12-01 - 2029-03-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting9Sites

2021-03-01 - 2026-12-30

Phase I

Active
  • Condition/Disease

  • Test Drug

Participate Sites
6Sites

Recruiting6Sites

2019-10-04 - 2020-12-28

Phase I

A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GS-4224 in Healthy Volunteers and Subjects with the Chronic Hepatitis B (CHB) Virus
  • Condition/Disease

    Chronic Hepatitis B

  • Test Drug

    GS-4224 Film-coated Tablets, 10mg and 100mg

Participate Sites
4Sites

Recruiting4Sites

1 2